Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Attention, inhibition, and proximity to clinical onset in preclinical mutation carriers for Huntington's disease.

Journal of clinical and experimental neuropsychology - 1 Apr 2007

Farrow Maree, Churchyard Andrew, Chua Phyllis, Bradshaw John L, Chiu Edmond, Georgiou-Karistianis Nellie

Abstract excerpt

Research in preclinical mutation carriers for Huntington's disease (HD) aims to find measures sensitive to preclinical decline. This study investigated attentional abilities in mutation carriers and noncarriers. Mutation carriers demonstrated a normal "attentional blink" during rapid serial visual presentation, normal covert visual orienting, and normal directing of attention to tactile stimuli. However, they...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Attention
Share to Cues

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Huntington Disease

Share to Inhibition, Psychological

Share to Neuropsychological Tests

Share to Psychomotor Performance

Share to Vibration

Source

Identifiers

PMID: 17454345
DOI: 10.1080/13803390600657693

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Attention, inhibition, and proximity to clinical onset in preclinical mutation carriers for Huntington's disease.PMID 17454345Read ↗

Modulation of inhibition of return by the dopamine D2 receptor agonist bromocriptine depends on individual DAT1 genotype.Semantic proximity Read ↗

Responsiveness to distracting stimuli, though increased in Parkinson's disease, is decreased in asymptomatic PINK1 and Parkin mutation carriers.Semantic proximity Read ↗

Identification of an oculomotor biomarker of preclinical Huntington diseaseSemantic proximity Read ↗

Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer’s diseaseSemantic proximity Read ↗

Age-dependent cognitive changes in carriers of the fragile X syndrome.Semantic proximity Read ↗

Demographic-Adjusted Normative Equations for the Oculo-Cognitive Addition Test (OCAT): A Foundation for Individualized Oculo-Cognitive AssessmentSemantic proximity Read ↗

Visual Working Memory Impairment in Premanifest Gene-Carriers and Early Huntington's Disease.Semantic proximity Read ↗

Psychomotor, executive, and memory function in preclinical Huntington's disease.Semantic proximity Read ↗

Characterization of visual cognition in pre-manifest, manifest and reduced penetrance Huntington’s diseaseSemantic proximity Read ↗

Attentional compensation in neurodegenerative diseases: the model of premanifest Huntington’s disease mutation carriersSemantic proximity Read ↗

Eye-tracking indices of impaired encoding of visual short-term memory in familial Alzheimer's disease.Semantic proximity Read ↗

Aspects of Attention in Rett Syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.